
Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States
Author(s) -
Colleen S. Kraft,
Aneesh K. Mehta,
Jay B. Varkey,
G. Marshall Lyon,
Sharon Vanairsdale,
Sonia Bell,
Eileen M. Burd,
Mary Elizabeth Sexton,
Leslie Anne Cassidy,
Patricia Olinger,
K Rengarajan,
Vanessa Raabe,
Emily Davis,
Scott Henderson,
Paula DesRoches,
Yongxian Xu,
Mark J. Mulligan,
Bruce S. Ribner
Publication year - 2020
Publication title -
infection control and hospital epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.243
H-Index - 138
eISSN - 1559-6834
pISSN - 0899-823X
DOI - 10.1017/ice.2019.349
Subject(s) - ebola virus , medicine , lassa virus , vp40 , virology , lassa fever , seroconversion , vaccination , asymptomatic , infection control , virus , immunology , intensive care medicine
Healthcare personnel (HCP) were recruited to provide serum samples, which were tested for antibodies against Ebola or Lassa virus to evaluate for asymptomatic seroconversion.